skip to Global Navigation Bar skip to main content

homeHome > About Us > Press Release > News


News Content
FDA resumes review of Daewoong Pharmaceutical’s Nabota
Date 2018-08-30 Hit 780
News List
Prev Nabota received approval from Health Canada
Next Daewoong Pharmaceutical signs export contract to New Zealand and Israel with Nabota